Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00051428 · ClinicalTrials.gov registry record · Phase 1

The Efficacy of Reiki in the Treatment of Fibromyalgia

A Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).

Completed
Registry status
Phase 1
Development phase
100
Enrollment target

NCT00051428: Completed Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).

NCT00051428 is a Phase 1 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 100 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00051428, a Phase 1 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).

COMPLETED
Registry status
Phase 1
Development phase
100 participants
Enrollment target

Study Summary

The purpose of this study is to investigate the effectiveness of Reiki in the treatment of fibromyalgia (FM), a condition characterized by widespread muscle pain and stiffness, often accompanied by sleep disturbance, headaches, irritable bowel syndrome, and psychological distress. Reiki is a form of energy medicine in which practitioners reportedly access universal life energy to heal patients, either by direct contact at specific hand positions or from a distance.

Interventions

  • PROCEDURE Reiki (distant and direct-contact)

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2003-01
Est. Completion 2005-02
Phase Phase 1

What the finished NCT00051428 record still lists

NCT00051428 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% higher).

The record links to 0 conditions, and to 1 intervention - of which Reiki (distant and direct-contact) is the first listed.

NCT00051428 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00051428 about?

NCT00051428 is a clinical study titled "The Efficacy of Reiki in the Treatment of Fibromyalgia". The purpose of this study is to investigate the effectiveness of Reiki in the treatment of fibromyalgia (FM), a condition characterized by widespread muscle pain and stiffness, often accompanied by sleep disturbance, headaches, irritable bowel syndrome, and psychological distress. Reiki is a form of...

What is the current status of trial NCT00051428?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 100 participants. The study started on 2003-01. Estimated completion is 2005-02.

What interventions are being tested in trial NCT00051428?

The interventions under investigation include: Reiki (distant and direct-contact) (PROCEDURE).

Who is sponsoring clinical trial NCT00051428?

This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00051428's enrollment target sits among peer trials

100 546th of 2000 higher than 1,411 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00051428, the US trial registry maintained by the National Library of Medicine. NCT00051428 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.